Your browser doesn't support javascript.
loading
Anesthetic Management for Ventricular Tachycardia Ablation: A National Anesthesia Clinical Outcomes Registry Analysis.
Dada, Rachel S; McGuire, Joseph A; Hayanga, J W Awori; Thibault, Dylan; Schwartzman, David; Ellison, Matthew; Hayanga, Heather K.
Affiliation
  • Dada RS; Anesthesiology Institute, Cleveland Clinic Foundation, Cleveland, OH.
  • McGuire JA; Department of Anesthesiology, West Virginia University, Morgantown, WV.
  • Hayanga JWA; Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV.
  • Thibault D; Department of Cardiovascular and Thoracic Surgery, West Virginia University, Morgantown, WV.
  • Schwartzman D; Division of Cardiology, Department of Medicine, West Virginia University, Morgantown, WV.
  • Ellison M; Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology, West Virginia University, Morgantown, WV.
  • Hayanga HK; Division of Cardiovascular and Thoracic Anesthesiology, Department of Anesthesiology, West Virginia University, Morgantown, WV. Electronic address: heather.hayanga@wvumedicine.org.
J Cardiothorac Vasc Anesth ; 38(3): 675-682, 2024 Mar.
Article in En | MEDLINE | ID: mdl-38233244
ABSTRACT

OBJECTIVES:

The authors analyzed anesthetic management trends during ventricular tachycardia (VT) ablation, hypothesizing that (1) monitored anesthesia care (MAC) is more commonly used than general anesthesia (GA); (2) MAC uses significantly increased after release of the 2019 Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias; and (3) anesthetic approach varies based on patient and hospital characteristics.

DESIGN:

Retrospective study.

SETTING:

National Anesthesia Clinical Outcomes Registry data.

PARTICIPANTS:

Patients 18 years or older who underwent elective VT ablation between 2013 and 2021.

INTERVENTIONS:

None. MEASUREMENTS AND MAIN

RESULTS:

Covariates were selected a priori within multivariate models, and interrupted time-series analysis was performed. Of the 15,505 patients who underwent VT ablation between 2013 and 2021, 9,790 (63.1%) received GA. After the 2019 Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias supported avoidance of GA in idiopathic VT, no statistically significant increase in MAC was evident (immediate change in intercept post-consensus statement release adjusted odds ratio 1.41, p = 0.1629; change in slope post-consensus statement release adjusted odds ratio 1.06 per quarter, p = 0.1591). Multivariate analysis demonstrated that sex, American Society of Anesthesiologists physical status, age, and geographic location were statistically significantly associated with the anesthetic approach.

CONCLUSIONS:

GA has remained the primary anesthetic type for VT ablation despite the 2019 Expert Consensus Statement on Catheter Ablation of Ventricular Arrhythmias suggested its avoidance in idiopathic VT. Achieving widespread clinical practice change is an ongoing challenge in medicine, emphasizing the importance of developing effective implementation strategies to facilitate awareness of guideline release and subsequent adherence to and adoption of recommendations.
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Tachycardia, Ventricular / Catheter Ablation / Anesthetics Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Tachycardia, Ventricular / Catheter Ablation / Anesthetics Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2024 Type: Article